Long-Acting β<SUB>2</SUB>-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Abstract

Patients with persistent asthma well controlled by low doses of triamcinolone cannot be switched to salmeterol monotherapy without risk of clinically significant loss of asthma control.